|
Special Report - Special Report - October 25, 2012 |
Newswise
Screening practices for multidrug-resistant organisms (MDROs) in intensive care units vary widely from hospital to hospital, says a new study by researchers at Columbia University School of Nursing and published in the October 2012 issue of the American Journal of Infection Control.
Researchers found that of the hospitals surveyed, more than half (59 percent) routinely screened for methicillin-resistant Staphylococcus aurea, or MRSA. Other potentially deadly MDROs were screened for...
If you are a subscriber or have purchased this article, please login to view this article in it's entirety.
Researchers found that of the hospitals surveyed, more than half (59 percent) routinely screened for methicillin-resistant Staphylococcus aurea, or MRSA. Other potentially deadly MDROs were screened for...
Article Options:
Purchase Full Article - $1.50 | Subscribe Online | Current Subscribers: Login
If you are a subscriber or have purchased this article, please login to view this article in it's entirety.
Subscribers have access to articles up to one year old. Purchased articles can be accessed in your account for 30 days.



